Abstract
74P Tumor agnostic comparison of immunohistochemistry and next-generation sequencing in detecting ALK fusions and assessment of ALK tyrosine kinase inhibitor efficacy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have